Brainstem gliomas are a heterogenous group of tumors whose biological behavior depends upon anatomical location. Gliomas of the brainstem comprise 15-20% of brain tumors in children. The majority of these are diffusely infiltrative gliomas of the ventral pons, a devastating cancer that occurs in school age children (peak at age 7) and almost invariably results in death. In dramatic contrast, gliomas occurring in the dorsal pons, midbrain or medulla are classically indolent and carry an excellent prognosis. This sharp anatomic and pathological division between gliomas of the ventral pons (diffuse intrinsic pontine glioma) and those occurring dorsally suggests dysregulation of an underlying cellular or microenvironmental process that is yet to be defined. I hypothesize that pediatric ventral pontine gliomas arise via specific dysregulation of a postnatal precursor cell, microenvironmental niche, or both. In support of this hypothesis, preliminary studies identify a novel population of neural precursor cells in the human ventral pons during childhood. We have also generated the first available cell culture of a human ventral pontine glioma and have isolated from the tumor a neural stem-like cell type. This represents a major advance in the study of this tumor, which has been limited to date by a dearth of tissue available for research and no experimental model system. The proposed experimental plan outlines a systematic evaluation of the normal human and mouse brainstem for stem, lineage-restricted precursor and glial cell populations in the ventral-dorsal axis, as well as a similarly systematic examination of ventral-dorsal differences in the signaling microenvironment of the postnatal brainstem, and finally testing the functional significance of identified candidate signaling pathways and a putative cell of origin in diffuse intrinsic pontine glioma cells. Techniques employed will include fluorescent immunohistochemistry and confocal microscopy, immuno-laser capture microdissection, cell culture, transplantation studies, FACS, gene expression microarray analysis, single cell PCR and genetic cell fate mapping. I am a neurologist who completed PhD training in neuroscience;my thesis project explored microenvironmental determinants of postnatal hippocampal neural precursor cell fate. I am now completing a fellowship in neuro-oncology, and focusing my future research efforts on postnatal developmental mechanisms in brain tumor pathophysiology. This proposed research plan draws upon my background in postnatal stem and precursor cell biology, and offers the critical opportunity to develop and hone the molecular biology skills necessary for my successful transition to independence in the field of developmental neuroscience. My mentor Dr. Beachy and Co-Mentor Dr Rowitch will provide an ideal environment to develop such skills and to immerse myself in the study of developmental signaling biology in brain cancer. I will receive both didactic and hands-on training in numerous molecular techniques and will be surrounded by the technological and intellectual support to succeed.

Public Health Relevance

Brainstem gliomas of childhood account for up to 20% of pediatric brain tumors, are frequently fatal and are poorly understood. By studying the normal brainstem during childhood, this project seeks to identify the cell of origin and molecular factors that may result in the growth of these devastating tumors. We will test the functional significance of the findings about the normal brainstem in brainstem tumor cells, which may ultimately result in new therapies for this tragic disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08NS070926-01
Application #
7953217
Study Section
NST-2 Subcommittee (NST)
Program Officer
Fountain, Jane W
Project Start
2010-07-01
Project End
2015-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
1
Fiscal Year
2010
Total Cost
$168,249
Indirect Cost
Name
Stanford University
Department
Neurology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Vinci, Mara; Burford, Anna; Molinari, Valeria et al. (2018) Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. Nat Med 24:1204-1215
Johung, Tessa B; Monje, Michelle (2017) Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets. Curr Neuropharmacol 15:88-97
Lin, Grant L; Monje, Michelle (2017) A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG). J Vis Exp :
Gholamin, Sharareh; Mitra, Siddhartha S; Feroze, Abdullah H et al. (2017) Disrupting the CD47-SIRP? anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Sci Transl Med 9:
Grasso, Catherine S; Tang, Yujie; Truffaux, Nathalene et al. (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555-9
Venkatesh, Humsa S; Johung, Tessa B; Caretti, Viola et al. (2015) Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell 161:803-16
Taylor, Kathryn R; Mackay, Alan; Truffaux, Nathalène et al. (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46:457-461
Caretti, Viola; Sewing, A Charlotte P; Lagerweij, Tonny et al. (2014) Human pontine glioma cells can induce murine tumors. Acta Neuropathol 127:897-909
Gibson, Erin M; Purger, David; Mount, Christopher W et al. (2014) Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344:1252304
Caretti, Viola; Bugiani, Marianna; Freret, Morgan et al. (2014) Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathol 128:605-7

Showing the most recent 10 out of 16 publications